Kayexalate Sodium

Sodium Polystyrene Sulfonate, the active ingredient in Kayexalate Sodium, is an ion‑exchange resin presented as an oral/rectal powder for oral and rectal use. It binds excess potassium in the gastrointestinal tract to treat hyperkalemia in patients with elevated serum potassium levels, particularly in acute care settings.

GNH USA supplies Kayexalate Sodium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support import and clinical use.

Kayexalate Sodium is used to lower elevated potassium levels in conditions associated with hyperkalemia.

- Hyperkalemia: reduces serum potassium concentrations to safer levels. - Acute potassium overload: facilitates rapid potassium removal in emergency situations. - Chronic kidney disease with hyperkalemia: helps maintain potassium balance in patients with reduced renal excretion.

Kayexalate Sodium may cause gastrointestinal and systemic adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Vomiting: occasional expulsion of stomach contents. - Constipation: reduced bowel movements. - Diarrhea: loose stools. - Abdominal pain: cramping or discomfort. - Flatulence: increased gas.

Serious or Rare Side Effects: - Intestinal necrosis: tissue death in the bowel. - Colonic perforation: a hole in the colon wall. - Severe electrolyte disturbances: abnormal sodium or calcium levels. - Allergic reactions: rash, itching, or swelling. - Hypernatremia: elevated blood sodium concentration. - Severe constipation leading to obstruction: blockage of intestinal flow.

Before prescribing Kayexalate Sodium, clinicians should evaluate patient‑specific factors and monitor for potential complications. - Renal function assessment: evaluate kidney function before initiating therapy. - Serum potassium monitoring: check potassium levels regularly during treatment. - Electrolyte balance: monitor sodium and other electrolytes to avoid imbalances. - Gastrointestinal risk: use caution in patients with bowel disorders or recent surgery. - Drug interactions: review concomitant medications that may affect potassium. - Store at ambient temperature: keep in original container, protect from moisture and heat.

Kayexalate Sodium can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Sodium polystyrene sulfonate with sorbitol: increased risk of colonic necrosis. - Concurrent use with potassium‑sparing diuretics: may blunt potassium‑lowering effect. - Co‑administration with ACE inhibitors or ARBs: heightened risk of hyperkalemia if resin is ineffective.

Moderate Interactions (Monitor Closely): - Antacids containing magnesium or aluminum: may reduce resin binding capacity. - Oral iron supplements: may interfere with potassium exchange. - Lithium therapy: monitor lithium levels as resin may affect absorption.